Taysha Gene Therapies Inc. (TSHA)
NASDAQ · Healthcare
Taysha Gene Therapies Inc. Cash Flow 2022–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Cash Flow | -93.1M | -81.2M | -73.0M | -88.4M | -117.0M | -30.7M |
| Depreciation & Amort. | — | — | — | — | — | — |
| Investing Activities | ||||||
| Capital Expenditure | 738,000 | 374,000 | 3.9M | 20.6M | 15.3M | 82,000 |
| Free Cash Flow | -93.8M | -81.6M | -76.9M | -109.0M | -132.3M | -30.8M |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — | — |
Taysha Gene Therapies Inc. Cash Flow — FAQ
Taysha Gene Therapies Inc. (TSHA) cash flow over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TSHA's cash flow history?
The chart and table above show Taysha Gene Therapies Inc.'s cash flow by year and by quarter, including the growth rate.